Sign in Subscribe
Cancer research

Small Bowel Cancer Treatment Strategies Show Promise

Strategic Insights

— 1 min read

Fresh data on Oncology - Small Bowel Cancer have been presented in a new report by researchers at the Mashhad University of Medical Sciences. The study, which examined the current evidence on targeted therapy and immunotherapy for Small Bowel Cancer (SBC), found that these treatments may have the potential to improve survival rates in patients with SBC. The researchers highlighted the importance of further research to determine the optimal combination of targeted therapy and immunotherapy for individual patients with SBC.

Key Takeaways:

  • The study found that targeted therapy and immunotherapy can have the potential to improve survival rates in patients with SBC.
  • The most promising targeted medicines for SBC treatment include bevacizumab, cetuximab, and trastuzumab.
  • Immunotherapies such as pembrolizumab and nivolumab show potential for SBC treatment.
  • The magnitude of the increase in survival rates with these interventions was small.
  • The study included 17 clinical trials and 10 case reports, indicating a need for further research.
  • The researchers emphasized the importance of exploring novel treatment approaches for SBC, given its rare and aggressive nature.

Statistics:

  • 17 clinical trials were included in the review of targeted therapy and immunotherapy for SBC.
  • 10 case reports were included in the review of targeted therapy and immunotherapy for SBC.
  • The increase in survival rates with targeted therapy and immunotherapy was small, according to the study.
  • The study was published in Naunyn-Schmiedeberg's Archives of Pharmacology in 2024.
  • The research was conducted by a team of researchers from the Mashhad University of Medical Sciences, led by Omid Arasteh.

Sources:

  • Naunyn-Schmiedeberg's Archives of Pharmacology, "Enhancing Treatment Strategies for Small Bowel Cancer: a Clinical Review of Targeted Therapy and Immunotherapy Approaches", 2024; 397(7): 4601-4614.
  • Mashhad University of Medical Sciences, School of Pharmacy, Dept. of Clinical Pharmacy.
  • PubMed, Scopus, and Google Scholar databases.
  • Springer, Naunyn-Schmiedeberg's Archives of Pharmacology, One New York Plaza, Suite 4600, New York, NY, United States.

Read more